Učitavanje...
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
Despite the success of the combination of venetoclax with the hypomethylating agents (HMA) decitabine or azacitidine in inducing remission in older, previously untreated patients with acute myeloid leukemia (AML), resistance - primary or secondary - still constitutes a significant roadblock in the q...
Spremljeno u:
| Izdano u: | Cancer Drug Resist |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
OAE Publishing Inc.
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8011583/ https://ncbi.nlm.nih.gov/pubmed/33796823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2020.95 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|